Immunomodulatory agents Flashcards
MOA apremilast:
- Phosphodiesterase-4 inhibitor (PDE-4 inhibitor)
- Ricky bobby voice: “if you “4th (PDE-4)” you’re “last (apremilast)”
Name the Janus kinase inhibitors:
- Tofacitinib
- Ruxolitinib
JAK- RT, pronounce “JAKeRT”
Tofacitinib MOA:
- JAK 1 and 3 inhibitor
Ruxolitinib MOA:
- JAK 1 and 2 inhibitor
Azathioprine MOA:
- inhibits purine metabolism and cell division (particularly in fast growing cells like lymphocytes)
What converts azathioprine into inactive metabolites?
- Xanthine oxidase and thiopurine methyltransferase (TPMT)
Most common AE of azathioprine?
- GI upset (nausea, vomiting, diarrhea)
AE’s of azathioprine:
- immunosuppression
- leukopenia, thrombocytopenia
- SCC and lymphoma
Azathioprine is pregnancy category ____
- D
- get pregnancy test before starting any woman of childbearing age
Cyclosporine MOA:
- inhibits calcineurin, which downstream will decrease IL-2 production—> decreased numbers of CD4 and CD8 cells
AE’s of cyclosporine
- nephrotoxicity and HTN are the two most notable AE’s and are dose dependent.
- gingival hyperplasia
- hypertrichosis
Cyclosporine should be _____ adjusted and should not be prescribed for more than ____ amount of time in a row
- renally adjusted at it is nephrotoxic
- maximum of one year of continual treatment
Psoriasis patients on cyclosporine therapy for >2 years have increased risk of _____
- NMSC
Lab/vitals to check prior to cyclosporine administration:
- kidney function (nephrotoxic)
- Blood pressure (can cause HTN)
- uric acid (can cause hyperuricemia/gout)
How often to recheck labs when on cyclosporine?
- every 2 weeks for first 2 months, then once monthly